Hailin Zou
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ 9
-
- Epigenetics and DNA Methylation 4
- Wnt/β-catenin signaling in development and cancer 4
- Pluripotent Stem Cells Research 3
- RNA modifications and cancer 2
- CRISPR and Genetic Engineering 2
- Cancer-related gene regulation 2
-
- Ocular Oncology and Treatments 3
- Co-authors
- Juan LuoYibo GuoPeng LiLiang DengTongyu TongYihang PanYun WangJingxuan Pan
- Journals
- Oncogene (2 papers)British Journal of Cancer (1 paper)Cellular and Molecular Life Sciences (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hailin Zou
15 papers receiving 397 citations
Peers
Comparison fields: 5 of 68
- Cell Biology 127
- Cancer Research 68
- Molecular Biology 274
- Oncology 94
- Ophthalmology 26
Countries citing papers authored by Hailin Zou
This map shows the geographic impact of Hailin Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailin Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailin Zou more than expected).
Fields of papers citing papers by Hailin Zou
This network shows the impact of papers produced by Hailin Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailin Zou. The network helps show where Hailin Zou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hailin Zou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 15 | |
| 8 | 2024 | 7 | |
| 9 | 2023 | 45 | |
| 10 | 2023 | 38 | |
| 11 | 2023 | 21 | |
| 12 | 2022 | 41 | |
| 13 | 2022 | 23 | |
| 14 | 2022 | 71 | |
| 15 | 2021 | 33 | |
| 16 | 2021 | 5 | |
| 17 | 2021 | 2 | |
| 18 | 2021 | 6 | |
| 19 | 2020 | 43 | |
| 20 | 2019 | 49 |
About Hailin Zou
Hailin Zou is a scholar working on Cell Biology, Ophthalmology and Molecular Biology, having authored 20 papers that have together received 400 indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (9 papers), Epigenetics and DNA Methylation (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Pluripotent Stem Cells Research (3 papers), Ocular Oncology and Treatments (3 papers), RNA modifications and cancer (2 papers), CRISPR and Genetic Engineering (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cell Biology (127 citations), Cancer Research (68 citations) and Molecular Biology (274 citations). Hailin Zou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Juan Luo, Yibo Guo, Peng Li, Liang Deng, Tongyu Tong, Yihang Pan, Yun Wang, Jingxuan Pan, Bo Wang and Liping Ye. Their work appears in journals such as Oncogene, British Journal of Cancer and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.